ADENOSINE A2 RECEPTORS AND PSYCHOSTIMULANT INTERACTIONS
ADENOSINE A2 RECEPTORS AND PSYCHOSTIMULANT INTERACTIONS
批准号:
2517911
负责人:
MICHAEL A SCHWARZSCHILD
金额:
$27.44万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 2000-08-31
关键词:
adenosine amphetamines behavioral habituation /sensitization corpus striatum dopamine receptor drug addiction antagonist drug administration rate /duration drug interactions gel mobility shift assay immunocytochemistry in situ hybridization laboratory rat limbic system messenger RNA neural plasticity neurochemistry neurons neuropharmacology nucleoproteins prosencephalon psychotropic drugs purinergic receptor receptor expression transcription factor western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract)
Long-term administration of psychostimulant drugs produces enduring
changes in behavior. It is likely that the long-term changes in brain
function associated with prolonged drug exposure are important to addictive
behavior. The molecular mechanisms underlying the persistent alteration in
brain function associated with prolonged psychostimulant exposure are poorly
understood. The behavioral effects of the psychostimulant amphetamine are
dependent on activation of dopamine receptors within the striatum and limbic
forebrain. Repeated administration of psychostimulants to rodents produces
alterations in nuclear proteins which may underlie long-lasting changes in
behavior. The A2a subtype of adenosine receptor is expressed in and
regulates responsiveness of D2-expressing striatal and limbic forebrain
neurons, and modulates the behavioral and nuclear responses of acute
amphetamine. The A1 adenosine receptor also modulates AMPH-induced
behavior, but the anatomical basis of this A1 effect is not understood. We
hypothesize that striatal and limbic forebrain A2a and A1 adenosine
receptors are sites where the acute effects of AMPH and enduring changes in
brain function following chronic AMPH can be regulated. The expression of
striatal and limbic forebrain A2a and A1 receptors will be characterized and
the roles that these adenosinergic receptors play in modulating the
behavioral and nuclear effects of acute and chronic AMPH administration will
be investigated. These experiments will begin to identify nuclear
mechanisms underlying this form of drug-induced neural plasticity which are
vulnerable to modulation by forebrain adenosinergic receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Planning for Prevention of Parkinson's Disease: a trial design forum
-
批准号:10827547
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2023
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2019 Parkinson Study Group Symposium and Training
-
批准号:9763271
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:10427325
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:9978147
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:10640903
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Urate-LRRK2 interactions in Parkinson's disease
-
批准号:10210454
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2019 Parkinson Study Group Symposium and Training
-
批准号:9890023
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2019
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2017 Parkinson Study Group Symposium and Training
-
批准号:9398499
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2017
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9292399
-
项目类别:
-
资助金额:$338.88万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9258571
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9129755
-
项目类别:
-
资助金额:$533.49万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Phase 3 trial of inosine for Parkinson's disease CCC
-
批准号:9547938
-
项目类别:
-
资助金额:$287.4万
-
财政年份:2015
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2014 Parkinson Study Group Symposium and Training
-
批准号:8838558
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2014
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Role of urate in protecting mitochondrial function in the brain
-
批准号:8676952
-
项目类别:
-
资助金额:$25.23万
-
财政年份:2013
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Role of urate in protecting mitochondrial function in the brain
-
批准号:8597004
-
项目类别:
-
资助金额:$21.76万
-
财政年份:2013
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
2013 Parkinson's Study Group Symposium
-
批准号:8651135
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2013
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Uric Acid:novel therapeutic target for Parkinson's Disease
-
批准号:7862626
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2009
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Pursuing purine pathways to clinical trials for Parkinson's disease
-
批准号:8265936
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2008
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Pursuing purine pathways to clinical trials for Parkinson's disease
-
批准号:7681629
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2008
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
Pursuing purinergic pathways to clinical trials for Parkinson's disease
-
批准号:7532911
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2008
-
负责人:MICHAEL A SCHWARZSCHILD
-
依托单位:
海外基金